Partial rescue of a lethal phenotype of fragile bones in transgenic mice with a chimeric antisense gene directed against a mutated collagen gene
- PMID: 8022775
- PMCID: PMC44188
- DOI: 10.1073/pnas.91.14.6298
Partial rescue of a lethal phenotype of fragile bones in transgenic mice with a chimeric antisense gene directed against a mutated collagen gene
Abstract
Previously, transgenic mice were prepared that developed a lethal phenotype of fragile bones because they expressed an internally deleted mini-gene for the pro alpha 1(I) chain of human type I procollagen. The shortened pro alpha 1(I) chains synthesized from the human transgene bound to and produced degradation of normal pro alpha 1(I) chains synthesized from the normal mouse alleles. Here we assembled an antisense gene that was similar to the internally deleted COL1A1 minigene but the 3' half of the gene was inverted so as to code for an antisense RNA. Transgenic mice expressing the antisense gene had a normal phenotype, apparently because the antisense gene contained human sequences instead of mouse sequences. Two lines of mice expressing the antisense gene were bred to two lines of transgenic mice expressing the mini-gene. In mice that inherited both genes, the incidence of the lethal fragile bone phenotype was reduced from 92% to 27%. The effects of the antisense gene were directly demonstrated by an increase in the ratio of normal mouse pro alpha 1(I) chains to human mini-pro alpha 1(I) chains in tissues from mice that inherited both genes and had a normal phenotype. The results raise the possibility that chimeric gene constructs that contain intron sequences and in which only the second half of a gene is inverted may be particularly effective as antisense genes.
Similar articles
-
Transgenic mice that express a mini-gene version of the human gene for type I procollagen (COL1A1) develop a phenotype resembling a lethal form of osteogenesis imperfecta.J Biol Chem. 1991 Dec 5;266(34):23373-9. J Biol Chem. 1991. PMID: 1744131
-
Bone fragility in transgenic mice expressing a mutated gene for type I procollagen (COL1A1) parallels the age-dependent phenotype of human osteogenesis imperfecta.J Bone Miner Res. 1995 Dec;10(12):1837-43. doi: 10.1002/jbmr.5650101202. J Bone Miner Res. 1995. PMID: 8619363
-
An inbred line of transgenic mice expressing an internally deleted gene for type II procollagen (COL2A1). Young mice have a variable phenotype of a chondrodysplasia and older mice have osteoarthritic changes in joints.J Clin Invest. 1993 Aug;92(2):582-95. doi: 10.1172/JCI116625. J Clin Invest. 1993. PMID: 8349798 Free PMC article.
-
Expression of type I procollagen genes.Ciba Found Symp. 1988;136:142-60. doi: 10.1002/9780470513637.ch10. Ciba Found Symp. 1988. PMID: 3068007 Review.
-
Mutations in type 1 procollagen that cause osteogenesis imperfecta: effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations, and potential antisense therapies.J Bone Miner Res. 1993 Dec;8 Suppl 2:S489-92. doi: 10.1002/jbmr.5650081311. J Bone Miner Res. 1993. PMID: 8122517 Review.
Cited by
-
Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin expression in the epidermis.J Cell Biol. 1996 Mar;132(5):925-36. doi: 10.1083/jcb.132.5.925. J Cell Biol. 1996. PMID: 8603923 Free PMC article.
-
Prospects for gene therapy in sports medicine.Knee Surg Sports Traumatol Arthrosc. 1996;4(3):180-7. doi: 10.1007/BF01577414. Knee Surg Sports Traumatol Arthrosc. 1996. PMID: 8961236 Review.
-
Antisense and ribozyme constructs in transgenic animals.Transgenic Res. 1996 Nov;5(6):363-71. doi: 10.1007/BF01980201. Transgenic Res. 1996. PMID: 8840519 Review.
-
Potential biomarkers of the mature intervertebral disc identified at the single cell level.J Anat. 2019 Jan;234(1):16-32. doi: 10.1111/joa.12904. Epub 2018 Nov 18. J Anat. 2019. PMID: 30450595 Free PMC article.
-
Gene therapy for inherited retinal degeneration.Br J Ophthalmol. 1997 Sep;81(9):795-801. doi: 10.1136/bjo.81.9.795. Br J Ophthalmol. 1997. PMID: 9422936 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous